FDA Inspection
Florida Institute for Reproductive MedicineFlorida Institute for Reproductive Medicine – FDA Inspection, Jan 6, 2020
Record Details
This FDA Inspection record concerns Florida Institute for Reproductive Medicine, with an inspection on January 6, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- January 6, 2020
- Product Type
- Biologics
View Company Profile
ID · 3c50678b-fc91-4a51-99dc-2c6a7ab27cff
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1119010
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Florida Institute for Reproductive Medicine
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 7, 2024 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 7, 2017 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 10, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 11, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Florida Institute for Reproductive Medicine
- FDA Inspection 1230530 - 2024-02-07
- FDA Inspection 1030849 - 2017-11-07
- FDA Inspection 947937 - 2015-11-10
- FDA Inspection 839966 - 2013-07-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.